Bilirubin levels >2 times along with alanine transaminase >3 times the upper normal limit are indicators of poor outcome following initiation of a drug, and should be evaluated by a hepatologist.11 A follow-up biopsy may be indicated to assess the resolution of granuloma, but it is not always necessary. This evidence concerns the gene GPT and Granuloma.